Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep Disturbances
Trial details
- Registry ID
- NCT05361707
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep DisturbancesNCT05361707 | Vanda Pharmaceuticals | Phase 3 | Unknown | 2025-07Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |